Your browser doesn't support javascript.
loading
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Hanbali, Amr; Kotb, Ahmed; Fakih, Riad El; Alfraih, Feras; Shihata, Nahla; Rasheed, Walid; Ahmed, Syed Osman; Shaheen, Marwan; Alhayli, Saud; Alahmari, Ali; Alotaibi, Ahmad; Alshaibani, Alfadel; Albabtain, Abdulwahab; Alfayez, Mansour; Hassan, Maha; Alsharif, Fahad; Chaudhri, Naeem; Almohareb, Fahad; Alzahrani, Hazzaa; Aljurf, Mahmoud.
Afiliação
  • Hanbali A; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Kotb A; Department of Medicine, Hematology unit, Zagazig University, Egypt.
  • Fakih RE; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alfraih F; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Shihata N; King Faisal Specialist Hospital, Jeddah, Saudi Arabia.
  • Rasheed W; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Ahmed SO; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Shaheen M; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alhayli S; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alahmari A; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alotaibi A; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alshaibani A; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Albabtain A; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alfayez M; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Hassan M; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alsharif F; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Chaudhri N; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Almohareb F; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Alzahrani H; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Aljurf M; Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Int J Hematol Oncol ; 12(1): IJH42, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36874377

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita País de publicação: Reino Unido